SeaSpine Holdings (SeaSpine Holdings) Days Sales Outstanding : 49.88 (As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

What is SeaSpine Holdings Days Sales Outstanding?

SeaSpine Holdings's average Accounts Receivable for the three months ended in Sep. 2022 was $36.7 Mil. SeaSpine Holdings's Revenue for the three months ended in Sep. 2022 was $67.1 Mil. Hence, SeaSpine Holdings's Days Sales Outstanding for the three months ended in Sep. 2022 was 49.88.

The historical rank and industry rank for SeaSpine Holdings's Days Sales Outstanding or its related term are showing as below:

SPNE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.9 Med: 60.37 Max: 65.59
Current: 55.54

During the past 10 years, SeaSpine Holdings's highest Days Sales Outstanding was 65.59. The lowest was 51.90. And the median was 60.37.

SPNE's Days Sales Outstanding is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 63.94 vs SPNE: 55.54

SeaSpine Holdings's Days Sales Outstanding declined from Sep. 2021 (57.71) to Sep. 2022 (49.88).

SeaSpine Holdings Days Sales Outstanding Historical Data

The historical data trend for SeaSpine Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeaSpine Holdings Days Sales Outstanding Chart

SeaSpine Holdings Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Sales Outstanding

Get a 7-Day Free Trial

59.33

53.70

51.90

60.37

59.47

SeaSpine Holdings Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Days Sales Outstanding	Get a 7-Day Free Trial															57.71	53.60	65.08	57.13	49.88

Competitive Comparison of SeaSpine Holdings's Days Sales Outstanding

For the Medical Devices subindustry, SeaSpine Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SeaSpine Holdings's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SeaSpine Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where SeaSpine Holdings's Days Sales Outstanding falls into.

SeaSpine Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

SeaSpine Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2021 is calculated as

	Days Sales Outstanding (A: Dec. 2021 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2020 )	+	Accounts Receivable (A: Dec. 2021 ))	/	count )	/	Revenue (A: Dec. 2021 )	*	Days in Period
=	( (26.154	+	36.231)	/	2 )	/	191.451	*	365
=	31.1925					/	191.451	*	365
=	59.47

SeaSpine Holdings's Days Sales Outstanding for the quarter that ended in Sep. 2022 is calculated as:

	Days Sales Outstanding (Q: Sep. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Sep. 2022 ))	/	count )	/	Revenue (A: Sep. 2022 )	*	Days in Period
=	( (34.441	+	38.969)	/	2 )	/	67.147	*	365 / 4
=	36.705					/	67.147	*	365 / 4
=	49.88

SeaSpine Holdings (NAS:SPNE) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

SeaSpine Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of SeaSpine Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

SeaSpine Holdings (SeaSpine Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SeaSpine Holdings Corp (NAS:SPNE) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

5770 Armada Drive, Carlsbad, CA, USA, 92008

Website

https://www.seaspine.com

SeaSpine Holdings Corp is a medical technology company. The company focuses on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. It has orthobiologics and spinal infusion hardware product categories. Its products are anterior and posterior fixation, access systems, bone graft substitutes, and collagen ceramic metrix. The company mainly operates in North America, Europe, Asia-Pacific, and Latin America. It generates revenue by consigning or loaning its products to hospitals and independent sales agents.

Executives

Shweta Maniar	director	C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Beau Standish	officer: President, Enabling Tech	C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Paul S. Benny	officer: VP, Corporate Controller	C/O SEASPINE HOLDINGS CORPORATION, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Renee Gaeta	director	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Angela Steinway	director	C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Michael Fekete	director	C/O SAGENT PHARMACEUTICALS, INC., 1901 NORTH ROSELLE ROAD, SUITE 700, SCHAUMBURG IL 60195
Tru St Partnership, L.p.	10 percent owner	795 EAST LANCASTER AVE., STE. 200, VILLANOVA PA 19085
Henneman John B Iii	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Richard E Caruso	10 percent owner	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Keith Valentine	officer: Chief Executive Officer	7475 LUSK BLVD., SAN DIEGO CA 92121
Kimberly Jo Tzoumakas	director	1170 FAIRFAX STREET, BIRMINGHAM MI 48009
Stuart Essig	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Dennis Cirino	officer: Senior VP, Spinal Systems	2361 LOZANA RD, DEL MAR CA 92014
Keith Bradley	director
Tyler Lipschultz	officer: SVP, Orthobiologics and BD	7475 LUSK BLVD, SAN DIEGO CA 92121